ArticleNPJ precision oncology2025
Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma.
Natalie Y L Ngoi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it